Moreover, high SYT11 expression displayed unfavorable disease-free survival (RFS) for patients with ACC (p = 0.0083), BLCA (p = 0.02), and COAD (p = 0.031) tumors (Fig. 2B), but not others (Supplementary Figs. 3 and 4). The gene discussed is SYT11; the disease is adrenal cortex carcinoma.